Axogen to acquire BioCircuit Technologies for $200M in cash
Tweet Send to a Friend
Axogen, Inc. (NASDAQ: AXGN) has entered into a definitive agreement to acquire BioCircuit Technologies, Inc., a privately held medical device ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


